Tuesday, January 10, 2023 4:02:37 PM
Surprised people aren't jumping on this opp
Recent CNTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 10:47:00 AM
- Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 • GlobeNewswire Inc. • 05/18/2026 10:45:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:20:00 PM
- Context Therapeutics Reports First Quarter 2026 Operating and Financial Results • GlobeNewswire Inc. • 05/06/2026 08:18:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:07:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:15:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:12:56 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 08:29:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 11:41:09 AM
- Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer • GlobeNewswire Inc. • 04/02/2026 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/23/2026 09:08:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:22:02 PM
- Context Therapeutics Reports Full Year 2025 Operating and Financial Results • GlobeNewswire Inc. • 03/23/2026 08:16:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:09:33 PM
- Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:09:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:11:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 09:24:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 09:18:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 09:13:57 PM
- Context Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/16/2026 09:05:00 PM
